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Background
• 72.7% of PLHIV know their status; 
89.6% on ART; 91.2% virally suppressed 
(MPHIA 2015-16).
• HIV testing coverage relatively low in 
men, adolescents and rural populations
Methods
• Cluster-randomised trial design
• Primary outcome: Self-reported HIV 
testing in the last 12 months
• Secondary outcome: Self-reported 
lifetime HIV testing and ART initiations
• Data sources: population-based 
surveys, clinic registers, routine data, 
social harms monitoring
3120 adults ≥ 16 years eligible 
for survey
2581 adults (82.8%) 
completed survey and 
included in analysis
Median cluster size
251 adults
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22 health facilities and defined 
catchment areas randomized
11 health facilities received 
community-based HIVST
43551 total adults ≥ 16 years 
Median cluster size
3752 adults
11 health facilities received 
standard of care
50089 total adults ≥ 16 years 
Median cluster size
3833 adults
1947 households enumerated 
in evaluation villages
1526 households (78.4%) 
randomly sampled
1407 households (92.2%)
responded
1782 households enumerated 
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1490 households (83.6%) 
randomly sampled
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Results – primary and secondary outcomes
HIVST SOC Unadj Risk Ratio (95% 
CI), p-value
Adj Risk Ratio1 (95% CI), 
p-value% (n/N) % (n/N)
Primary outcome: tested in the last 12 months
Overall 68.1%
(1758/2581)
48.4%
(1409/2908)
1.42 (1.20-1.68)
<0.001
1.33 (1.12-1.59)
0.003
Stratified by age
<20 years 69.5% 
(273/393)
42.4% 
(191/451)
1.77 (1.31-2.39)
<0.001
1.76 (1.32-2.34)
<0.001
≥ 20 years 67.9% 
(1485/2188)
49.6%
(1218/2457)
1.38 (1.16-1.63)
<0.001
1.29 (1.08-1.53)
0.007
P-value for interaction 0.08 0.14
Stratified by sex
Male 64.8% 
(697/1075)
41.7% 
(527/1264)
1.55 (1.24-1.94)
<0.001
1.50 (1.17-1.92)
0.003
Female 70.4% 
(1061/1506)
53.6%
(882/1644)
1.34 (1.14-1.57)
0.001
1.25 (1.05-1.48)
0.01
P-value for interaction 0.10 0.10
Stratified by assets index
Low 63.6%
(459/722)
47.0% 
(424/902)
1.31 (1.04-1.64)
0.02
1.27 (1.00-1.62)
0.05
Medium 70.9% 
(588/829)
51.5%
(447/868)
1.39 (1.18-1.63)
<0.001
1.28 (1.09-1.51)
0.005
P-value for interaction (medium vs low) 0.49 0.61
High 68.3% 
(656/961)
46.8% 
(474/1013)
1.52 (1.23-1.87)
<0.001
1.44 (1.16-1.80)
0.002
P-value for interaction (high vs low) 0.16 0.19
Secondary outcome: ever tested
Overall 86.9%
(2243/2581)
78.5% 
(2283/2908)
1.11 (1.06-1.16)
<0.001
1.08 (1.03-1.13)
0.004
Secondary outcome: ART initiation
HIVST SOC Unadj. GM Ratio 
(95% CI), p-value
Adj. GM Ratio 2
(95% CI), p-valueGM GM
Overall 167 212 1.27 (0.71-2.26)
0.40
1.14 (0.75-1.75)
0.52
1 Adjusted for 
cluster-level 
baseline recent 
testing and 
individual-level 
covariates age, sex 
and marital status. 
2 Adjusted for 
baseline (pre-
intervention) ART 
initiation.
Results – fidelity 
• 157 CBDAs delivered 
220,314 HIVST kits 
from 09/16-01/18. 
• Ever ST: HIVST, 42.5%; 
SOC, 8.3% 
• 1 mild and 2 severe 
adverse events from 
13,083 HIVST episodes 
in evaluation villages
Conclusions
• CBDA-delivered HIVST increased recent and lifetime testing coverage in rural 
populations, including among men and adolescents
• HIVST was acceptable and resulted in few social harms
• HIVST had no measurable impact on population-level ART initiation
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